Wockhardt News and Activities
Presence
Wockhardt is a pharmaceutical company that develops, manufactures, and markets medicines and healthcare products. Its main offerings include generic drugs, vaccines, and biologic treatments for hospitals, clinics, and patients.
Wockhardt products and services overview:
- Generic medicines
- Biologic therapies
- Vaccines
- Active ingredients
- Critical care
- Consumer healthcare
Revenue: ~$345 million
Employees: 3,000
Headquarters: Mumbai, India
Wockhardt is one of the...
Wockhardt is a company listed under the stock ticker WOCKPHARMA (IN).
Wockhardt has a direct presence in 2 countries.
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Wockhardt
- Murtaza Khorakiwala, Managing Director
- Habil Khorakiwala, Chairman of the Board
- Amelia Fernandes, Director
Popular executive movements at Wockhardt
- Bala Aiyaswamy has joined the company as Chief People Officer (posted on May 12 2026).
Create your alert
to follow the executive moves at Wockhardt.
Pharmaceuticals
Wockhardt has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- The new name of Stealth BioTherapeutics is Mighty Therapeutics. (posted on June 19 2026).
- Transcend has announced the acquisition of Otsuka America Pharmaceutical (posted on June 18 2026).
- Chiesi has announced the acquisition of Kalvista Pharmaceuticals (posted on June 18 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Wockhardt
Social media about Wockhardt
- Wockhardt on Wikipedia, Google News & Yahoo Finance
- Wockhardt on LinkedIn, X (Twitter) & YouTube
